How many acquisitions has Menarini made so far?

Menarini has completed 3 acquisitions so far, with an average acquisition amount of $372M.

In which year did Menarini make the most acquisitions?

Menarini was most active in 2020, with 1 acquisition completed in that year.

List of 3 Acquisitions by Menarini (Apr 2026)

Most viewed in 2019

Menarini has completed 3 acquisitions to date. Its 3 acquisitions have spanned 3 sectors: Genomics, Oncology, and Life Sciences Platforms and Tools, and occurred in 2 countries: United States and Italy. Peak acquisition years were 2020, 2018, and 2013, with one acquisition completed in each year. Over the 2020-2025 period, the average number of acquisitions per year is approximately 0.17. No acquisitions have been completed in the current calendar year so far. The most recent acquisition was StemlineTherapeutics, an oncology therapeutics innovator focused on transforming cancer patient lives. Founded in 2003, the company is based in New York City. This acquisition was completed in May 2020 for $677M.

Here's the year on year acquisition history of Menarini:

Number of Total Acquisitions

Year	# Acquisitions
2020	1
2018	1
2013	1

View all Acquisitions by Menarini

Recent acquisitions by Menarini

Menarini's most recent acquisition - StemlineTherapeutics is a Oncology therapeutics innovator focused on transforming cancer patient lives, founded in 2003 and located in New York City. Menarini acquired it in May 2020 for a price of $*****.

Here is the list of all acquisitions by Menarini sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
May 04, 2020	StemlineTherapeutics	nhsa	xurb	87	164
Oct 11, 2018	Orbactiv	jffw	znun	84	198
Sep 12, 2013	Silicon Biosystems	vlva	uffn	79	399

Media has covered Menarini for a total of 11 events in the last 1 year, 3 of them have been about acquisition activity.

•

Medidata & Menarini Group Expand Partnership for Oncology PipelineGlobeNewswire•Mar 09, 2026•Menarini, Medidata

•

ERBC and Menarini Biotech Partner to Accelerate Biopharmaceutical DevelopmentPR Newswire•Apr 04, 2025•ERBC, Menarini

•

ERBC and Menarini Biotech join forces to accelerate biopharmaceutical development from research to first-in-human clinical trialsPR Newswire•Apr 04, 2025•ERBC, Menarini

View More Menarini Recent News

View all Acquisitions by Menarini

Acquisitions by Menarini

List of Menarini's Acquisitions

Recent acquisitions by Menarini

News related to Menarini's acquisitions

FAQs about Acquisitions by Menarini